Artivion Operating Margin from 2010 to 2024
| AORT Stock | USD 26.99 0.22 0.81% |
Check Artivion financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Artivion's main balance sheet or income statement drivers, such as Depreciation And Amortization of 24.2 M, Selling General Administrative of 177 M or Total Revenue of 371.7 M, as well as many indicators such as Price To Sales Ratio of 2.79, Dividend Yield of 0.0062 or PTB Ratio of 3.06. Artivion financial statements analysis is a perfect complement when working with Artivion Valuation or Volatility modules.
Artivion | Operating Margin |
Latest Artivion's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Artivion over the last few years. It is Artivion's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Artivion's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0.08 % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Artivion Operating Margin Regression Statistics
| Arithmetic Mean | 0.04 | |
| Coefficient Of Variation | 140.20 | |
| Mean Deviation | 0.04 | |
| Median | 0.04 | |
| Standard Deviation | 0.05 | |
| Sample Variance | 0 | |
| Range | 0.1674 | |
| R-Value | (0.47) | |
| Mean Square Error | 0 | |
| R-Squared | 0.22 | |
| Significance | 0.08 | |
| Slope | (0.01) | |
| Total Sum of Squares | 0.04 |
Artivion Operating Margin History
About Artivion Financial Statements
Artivion shareholders use historical fundamental indicators, such as Operating Margin, to determine how well the company is positioned to perform in the future. Although Artivion investors may analyze each financial statement separately, they are all interrelated. The changes in Artivion's assets and liabilities, for example, are also reflected in the revenues and expenses on on Artivion's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company was founded in 1984 and is headquartered in Kennesaw, Georgia. Artivion operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 1300 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Artivion Stock Analysis
When running Artivion's price analysis, check to measure Artivion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artivion is operating at the current time. Most of Artivion's value examination focuses on studying past and present price action to predict the probability of Artivion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artivion's price. Additionally, you may evaluate how the addition of Artivion to your portfolios can decrease your overall portfolio volatility.